Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 1 041.58 0.5%

Annual report 2025
added 02-12-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

897 M

Market Cap[1]

$ 935 B

EBITDA (LTM)

$ 2.37 B

P/E (LTM)

76.26

P/S (LTM)

18.49

EPS (LTM)

13.74

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 14.81 -0.34 % $ 6.04 B Nasdaq Global Market irlandaIrlanda
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
$ 17.8 -1.44 % $ 18.7 B Nasdaq Global Select Market usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
$ 3.93 0.26 % $ 335 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Adagene Adagene
ADAG
$ 3.24 13.85 % $ 182 M Nasdaq Global Market chinaChina
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.79 -7.27 % $ 4.31 M Nasdaq Global Select Market chinaChina
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.48 -0.98 % $ 8.37 B Nasdaq Capital Market australiaAustralia
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Biogen Biogen
BIIB
$ 195.63 0.06 % $ 28.7 B Nasdaq Global Select Market,SPB usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Athira Pharma Athira Pharma
ATHA
- - $ 269 M Nasdaq Global Select Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 216.28 -0.83 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
$ 60.51 1.12 % $ 123 B NYSE,SPB usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
BioNTech SE BioNTech SE
BNTX
$ 106.24 0.45 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
- 17.91 % $ 11.1 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.41 1.81 % $ 360 M Nasdaq Global Select Market britainBritain
Burford Capital Limited Burford Capital Limited
BUR
$ 9.33 0.32 % $ 1.51 B NYSE britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
$ 14.8 1.13 % $ 4.57 B NYSE usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.